Tidal Investments’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.86M Buy
39,282
+8,531
+28% +$438K ﹤0.01% 1406
2026
Q1
$1.8M Buy
+30,751
New +$2M ﹤0.01% 1184
2025
Q4
Sell
-10,046
Closed -$627K 2282
2025
Q3
$627K Buy
+10,046
New +$699K ﹤0.01% 1444
2025
Q1
Sell
-3,424
Closed -$267K 1969
2024
Q4
$267K Sell
3,424
-1,380
-29% -$107K ﹤0.01% 1636
2024
Q3
$346K Sell
4,804
-393
-8% -$27.8K ﹤0.01% 1540
2024
Q2
$358K Sell
5,197
-551
-10% -$37.3K ﹤0.01% 1446
2024
Q1
$417K Buy
5,748
+256
+5% +$17.1K 0.01% 1262
2023
Q4
$336K Buy
5,492
+246
+5% +$14.6K 0.01% 1127
2023
Q3
$300K Sell
5,246
-198
-4% -$12K 0.01% 1063
2023
Q2
$324K Sell
5,444
-544
-9% -$32.6K 0.01% 1007
2023
Q1
$375K Buy
+5,988
New +$374K 0.01% 905

Other funds holding PBH

Tidal Investments's PBH Position: Q2 2026 in Review

Tidal Investments increased its Prestige Consumer Healthcare (PBH) stake by 28% in Q2 2026, buying an estimated $438K and bringing the position to 39,282 shares worth $1.86M. The position accounts for ﹤0.01% of the portfolio, ranked #1406.

Tidal Investments first reported a position in PBH in Q1 2023 and has held it in 11 quarters since. 320 funds tracked by Wall St. Rank hold PBH as of Q2 2026.

  • Tidal Investments held 39,282 shares of Prestige Consumer Healthcare worth $1.86M as of Q2 2026.
  • Tidal Investments bought 8,531 Prestige Consumer Healthcare shares in Q2 2026, an estimated $438K.
  • Prestige Consumer Healthcare made up ﹤0.01% of Tidal Investments's portfolio in Q2 2026, its #1406 holding.
  • Tidal Investments first reported a position in Prestige Consumer Healthcare in Q1 2023 and has held it in 11 quarters since.
  • 320 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2026.

Based on Tidal Investments's 13F filing for Q2 2026, filed 13 Aug 2026.